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AbstrACt
Objectives Patients with colorectal cancer undergoing 
palliative treatment receive extensive treatment-related 
information throughout their disease trajectory. We aimed 
to explore the experiences of patients with incurable 
colorectal cancer while in palliative care and their 
reflections on the information provided by physicians and 
nurses. Our main focus was the patients’ thoughts about 
how information about disease status and life expectancy 
was communicated, from the first time that they were 
informed about the incurable nature of their disease 
through to postsurgery palliative treatment.
settings Patients with colorectal cancer receiving 
palliative chemotherapy.
research design We used a qualitative approach, and 
the data were analysed by qualitative content analysis.
Participants 20 patients (34–75 years of age) were 
included in the study; 12 received first-line chemotherapy 
and 8 received second-line chemotherapy. Eleven patients 
were treated by oncologists, and nine were treated by 
junior physicians.
results Data-driven empirical analysis identified three 
themes: (1) inadequate information during the initial phase 
of the disease trajectory; (2) hope and information further 
into the disease trajectory and (3) personal, professional 
and organisational factors that influenced information and 
communication throughout the disease trajectory.
Conclusion The participants’ experience of being told 
for the first time that they had an incurable disease was 
perceived as inadequate, while postsurgery palliative 
chemotherapy, physicians and nurses offered hope. The 
participants preferred customised information about their 
treatment and likely future prospects and physicians and 
nurses who took a holistic and compassionate approach 
focusing on their lifeworld. To be a sensitive, holistic and 
compassionate physician or nurse requires knowledge and 
confidence. To achieve this requires training and guidance 
at universities and in hospitals.
bACkgrOund 
Patients with cancer who are treated with 
palliative intent receive extensive amounts 
of disease-related information from the first 
time they are informed about the incurable 
nature of their disease through the following 
months or years of treatment and care.1–4 
Guidelines encourage healthcare profes-
sionals (HCPs) such as physicians and nurses 
to keep patients informed and to discuss 
their prognoses and likely future prospects. 
However, many HCPs and patients struggle 
to find the right approach for these discus-
sions,5–9 and a primary focus on open commu-
nication regarding the bleak prospects for 
the patient’s life expectancy entails a risk of 
overwhelming the individual’s need for infor-
mation and their hope.10 In-depth studies 
of patients’ experiences about information 
given by physicians and nurses throughout 
their disease trajectory are needed to guide 
HCPs in how to communicate to patients 
strengths and limitations of this study
 ► In-depth and rich knowledge derived from the 
thoughts of 20 patients undergoing palliative care 
for colorectal cancer about how information about 
their disease, prognosis and life expectancy was 
communicated, starting from the first time that they 
were told that they had an incurable disease through 
to their postsurgery treatment.
 ► The qualitative design revealed that patients with 
colorectal cancer undergoing palliative care prefer 
health care professionals who are compassionate at 
all stages of their disease trajectory.
 ► It could be seen as a limitation that the study fo-
cused on one group of patients in palliative care, 
because this could limit the variation in findings that 
might have been evident with inclusion of more het-
erogeneous groups.
 ► We interviewed the patients at only one time point 
during chemotherapy and their memory about re-
ceiving their first information relating to their dis-
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undergoing palliative care information about their diag-
nosis and life expectancy.
Most studies focusing on patient–HCP communica-
tions about disease and prognosis in patients with incur-
able cancer are quantitative and involve patients at either 
an early or late stage of the disease.6 11 Qualitative studies 
report divergent results regarding the patient’s acceptance 
of the chronic and incurable nature of their disease and 
the presentation of their prognosis.11–17 Patients request 
that both disease-oriented and illness-oriented informa-
tion be provided by caring and trusted HCPs.13 14 17
Patients with cancer undergoing palliative treatment 
are vulnerable, and good patient–HCP relationships 
are important.18 Løgstrup19 emphasised the importance 
of trust and the patients’ vulnerability in such relation-
ships, while Mishler20 distinguished between the voice of 
medicine (the technical–scientific assumptions of medi-
cine) and the voice of the lifeworld (the natural attitudes 
of everyday life) in patient–physician communication. 
Mishler suggested an increased attentiveness to the voice 
of the patients in terms of their lifeworld, especially in 
vulnerable individuals such as patients in palliative care.
Patients often experience a life crisis when they are 
informed that their cancer is incurable.21 Over time, the 
majority adjust to their new life situation, and during this 
time, their preferences and experiences regarding infor-
mation and communication might change.18 Although 
colorectal cancer is one of the most common types of 
cancer,21 22 there is limited knowledge about how this 
patient group views information and communication 
about disease and life expectancy throughout their 
disease trajectory, because most studies include heteroge-
neous groups of patients. Treatment for colorectal cancer 
usually involves surgical removal of the tumour followed 
by adjuvant chemotherapy. Thus, most patients with 
colorectal cancer tend to have a similar disease trajectory, 
and knowledge about their experience and information 
preferences might be valuable to give patients better palli-
ative care.
We aimed to explore the experiences of patients with 
incurable colorectal cancer and their reflections on infor-
mation provided by physicians and nurses while they 
were in palliative care. Our main focus was the patients’ 
thoughts about how information about their disease, 
prognosis and life expectancy was communicated, from 
the first time that they were told that their disease was 
incurable through to postsurgery palliative treatment.
MethOds
We chose a qualitative inductive approach using in-depth 
interviews.23 As part of a larger study,24 we invited patients 
with metastatic colorectal cancer who were referred for 
palliative chemotherapy at three regional hospitals in 
Southern Norway to participate in this study. Oncolo-
gists informed patients about the study at the outpatient 
clinics when they attended for the second or third cycle 
of chemotherapy. Most participants were informed of 
their incurable diagnosis by surgeons, except for two who 
were informed by their general practitioners (GPs). All 
participants had undergone surgery for their cancer, and 
most had their surgery at relatively small hospitals, with 
surgeons being mainly responsible for the patients’ care 
and the communication in this phase. The participants 
spent only a few days in the surgery department with 
teams including few HCPs. Subsequently, chemotherapy 
was provided at an oncological outpatient clinic where 
oncologists were mainly responsible for the treatment. 
The participants visited the outpatient clinic for weeks or 
months.
The patients were eligible for inclusion if they were 
aged 18 years or older, had metastatic colorectal cancer, 
had undergone surgery for their cancer, had been 
referred for first-line or second-line palliative chemo-
therapy, had a life expectancy of >6 months and were able 
to give written informed consent. We included consecu-
tive patients of different ages and marital status and with 
varying demographic and clinical characteristics.25 We 
excluded patients with any significant comorbidity that 
could compromise their life expectancy, or who were 
unable to understand or read Norwegian. Patients with 
conditions that the physician believed could affect the 
patient’s ability to understand or cope with the questions 
were considered ineligible, including patients who were 
considered to be too emotionally vulnerable (n=4).
Twenty patients with colorectal cancer (34–75 years of 
age) were invited to participate in the study over a period 
of 1 year, and all accepted the invitation. All patients 
received combination chemotherapy (table 1) and had 
few physical symptoms related to their disease. The 
sample comprised 12 patients receiving first-line chemo-
therapy (five women and seven men) and eight receiving 
second-line chemotherapy (three women and five men). 







Mean age (range), years 63 (34–75) 69 (64–75)
Marital status:
  Married/cohabiting 10 8
  Single 1
  Widow/widower 1
Chemotherapy used
  Fliri/bevacizumab 10
  FLOX (5-fluorouracil, folinic 
acid, oxaliplatin)
1 8
  Capecitabine plus 
oxaliplatin (Xelox) 
1
All paticipants received 5-fluorouracil-based combination 
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Eleven patients were treated by oncologists, and nine 
were treated by junior physicians.
data collection
The same researcher (GR) conducted all the interviews. 
One interview took place at the patient’s home, and the 
other interviews took place at the cancer centre or outpa-
tient clinics at a time when the patients had an appoint-
ment. The researchers did not know the patients before 
the interviews and did not treat the patients. The meet-
ings were in-depth interviews lasting 50–100 min using 
a semistructured interview guide to ensure inclusion of 
the issues in focus,23 and questions such as: ‘What do 
you think about the first information that you received 
about your disease and its prognosis?’, ‘How was infor-
mation provided about the follow-up chemotherapy and 
likely future prospects?’, ‘Have you received the infor-
mation that you expected or is there anything missing?’ 
and ‘What things are important when giving information 
about your disease and prognosis, and how do you want it 
to be given/delivered?’ After conducting 11 interviews, we 
did some preliminary analyses and made minor changes 
to the interview guide to obtain more data on issues that 
needed to be expanded to address the research aim; for 
example, ‘What characterised the good information that 
you received versus other information that you were not 
happy with?’ Patients were included until data saturation 
was achieved, as indicated by only minor new informa-
tion being obtained in interviews 19 and 20.23 At 2–4 
days after each interview, GR contacted the patient and 
asked whether the interview had influenced him or her 
negatively. No patient experienced a negative influence 
or reaction.
Analysis
We audiotaped and transcribed the interviews verbatim 
and made logs after each interview. The data were anal-
ysed by qualitative content analysis to identify the themes 
in the data. For the analyses, we (1) read all the inter-
views to understand the meaning of the whole text, (2) 
investigated sentences or sections to clarify their meaning 
and to facilitate the identification of themes, (3) related 
sentences or sections to the meaning of the whole text 
and (4) identified passages representative of shared 
understanding between the researchers and partici-
pants. To support the analysis, we created mind maps and 
discussed the analysis. The analysis steps were followed 
carefully, which increased the reliability of the study. 
Quotations are used to illustrate and support the find-
ings, which increases their trustworthiness. To validate 
the findings, all authors participated in discussions of the 
empirical analysis and in writing up the findings. In the 
discussion, the findings were interpreted in light of our 
previous understanding. GR and US are both nurses and 
professors in health sciences with clinical experience in 
palliative care. IV is a gynaecologist and professor who 
also has extensive experience in treating patients with 
cancer who are undergoing palliative care.
Voluntariness and confidentiality were assured during 
the collection, handling and reporting of data.26 27 
Patient involvement
Before we started the study, we conducted three pilot 
interviews with patients with cancer to test the study 
design and the interview guide, and made minor changes 
to the guide. These interviews were not included in the 
study. There was no further patients’ involvement. The 
findings are given in this publication.
results
Through data-driven empirical analysis, we identified 
three themes: (1) inadequate information during the 
initial phase of the disease trajectory; (2) hope and 
information further into the disease trajectory and (3) 
personal, professional and organisational factors that 
influenced information and communication throughout 
the disease trajectory. We did not identify any differences 
between participants receiving first-line or second-line 
chemotherapy.
Inadequate information during the initial phase of the disease 
trajectory
The news that their cancer was incurable was given to 
patients at the surgical department or by the patient’s GP. 
Overall, how patients experienced receiving this informa-
tion varied: it could have been given earlier, it was expe-
rienced as a shock, it was insufficient, it was given in an 
inappropriate way or at an inappropriate place. However, 
some reported that they were satisfied with the way the 
information was given.
A few participants had to wait a long time (weeks or 
months) from their first concern about the disease 
until they were examined or had an appointment at the 
hospital. When the cancer was finally diagnosed, they 
received limited apologies for the delay from the physi-
cians, and emphasised that an apology would have made 
the situation easier to handle. Some had not even felt 
particularly ill, and it was hard for them to understand 
the message from the physician that they had an incur-
able disease. Several participants experienced the first 
information about the incurable nature of their disease 
as a shock.
When the surgeon gave me the message that my dis-
ease was incurable, I was shocked, I didn’t feel that 
anything was wrong. I asked him how long I had left 
to live. He just shrugged and didn’t have any answer. 
The conversation took 8 min (patient 4, woman aged 
54 years).
We did not identify any difference between the two 
participants who received the news from their GP 
compared with those who received it from their surgeon.
Some participants felt that the information given 
before and after their surgery was insufficient. The infor-
mation was brief, there was no time after the surgery for 
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the HCPs had not told them the whole truth. They would 
have liked more answers and sufficient communication 
with the surgeon.
I think she gave the message in three sentences. She 
said I had metastatic cancer. That’s it. I asked what it 
meant. ‘I don’t know’ she replied (patient 6, man 73 
years).
In contrast, some of the participants, males in particular, 
expressed satisfaction with how the surgeon had given 
preoperative and postoperative information and 
explained the surgery, its consequences and likely future 
treatment-related effects, for example, challenges with 
the stoma or the risk of impotence after the operation.
I was happy with the information the surgeon gave. I 
am a person who asks questions, and I am not afraid 
of asking. I received the answers I needed (patient 15, 
man aged 73 years).
A few participants reported that surgeons or GPs had 
given them the news in an inappropriate way or at an inap-
propriate place (eg, in a small examination room) and 
they experienced this as an extra burden. Further ques-
tions from the participants were answered to a limited 
extent, if at all. It was challenging to be told that their 
cancer could not be cured. A few participants received 
the message that a complete tumour resection was impos-
sible or that very little could be done. Such messages were 
experienced as a death sentence.
It’s important to tell the truth, but in an appropriate 
way. ‘Go home and die’. That’s not appropriate (pa-
tient 4, woman aged 54 years).
Although the message was brutal to hear, a few partici-
pants admitted that a straightforward message was prob-
ably the best way.
hope and information further into the disease trajectory
Postsurgery chemotherapy and further information and 
care were offered/given at the cancer centre. Hope was 
offered by the palliative chemotherapy itself, as well 
as by physicians and nurses, and there was variation in 
how much and how precise information the participants 
preferred in this phase.
When the participants started their postsurgery chemo-
therapy, some time had passed and further treatment 
implied hope that something could be done after all. 
The behaviour and attitudes of physicians and nurses 
also offered hope. At the cancer centre, the participants 
were met with openness, knowledge and sufficient time. 
The participants experienced that the physicians post-
poned death by offering chemotherapy, and the impor-
tance of including hope in patient communication was 
emphasised.
She asked about my background, she saw more than 
my illness. She looks at you. She gives you hope. That 
is how I want to be met (Patient 4, woman aged 54 
years).
The participants’ hopes seemed to change from before 
they were diagnosed with their incurable disease and 
through their disease trajectory. Physicians and nurses at 
the cancer centre conveyed that they would try to delay 
disease progress and relieve pain and symptoms. Even 
though they recognised that their cancer was incurable, 
most participants hoped that they would be among those 
who could live for years despite a poor prognosis. As the 
disease progressed, they hoped for good days, not extraor-
dinary things or experiences, and for some participants 
there seemed to be a change in goals and values.
Correct and truthful information about their disease, 
treatment effects, side effects, metastases and likely future 
prospects was important for the participants. Preferences 
varied regarding the amount of information they wanted 
to receive and at which time point. Some participants 
wanted a total overview of their disease and prognosis 
from the start, some wanted a smaller amount of infor-
mation at that time, while others wanted their body to tell 
them how their disease was progressing.
I don’t want to know the exact date. I would like in-
formation about disease progression and prognosis 
bit by bit, or let my body tell me bit by bit (patient 17, 
woman aged 71 years).
Some participants found vague information about 
likely prospects confusing. In particular, some of the male 
participants wanted straightforward information.
I would like to know even more if it is possible. I don’t 
want them to keep any information back. I would like 
to have a better overview and know what to expect in 
the future (patient 13, man aged 68 years).
During palliative chemotherapy, the participants had 
different experiences of receiving information about 
their life expectancy. Some found the information to be 
adequate, while others claimed that they had received 
non-specific information on this topic, if anything at all.
They haven’t said much about life expectancy. 
However, the treatment is palliative. They haven’t giv-
en me the time. And I haven’t asked (patient 7, man 
aged 63 years).
Personal, professional and organisational factors that 
influenced information and communication throughout the 
disease trajectory
Throughout their disease trajectory, the participants had 
experiences and preferences relating to personal, profes-
sional and organisational factors that influenced informa-
tion and communication. The participants experienced 
that in the surgery department, there was limited time for 
information and communication. They preferred HCPs 
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and that their healthcare is organised in such a way that it 
was possible to meet the same well-qualified HCPs.
Most participants met the surgeon once before the 
surgery and spent only a few days in the surgery depart-
ment. Some experienced that there was too little time for 
information and communication.
I only received a small amount of information at the 
surgical department. They just sent me home. You’re 
finished, you can leave. I would have liked more an-
swers (patient 20, man 74 years).
The combination of the professional knowledge and 
personality of the HCPs was emphasised as important. 
The participants strongly appreciated physicians and 
nurses who had enough time for them and who knew 
them and their disease. One participant characterised 
this as follows.
She is an oncologist with a heart and a brain (patient 
4, woman 54 years).
The participants wanted physicians and nurses who 
could see them as a person, not just as a patient. They 
emphasised the importance of the HCP paying atten-
tion, making them feel that there was time enough for 
discussions during the consultations or visits at the cancer 
centre for chemotherapy and knowing them without 
consulting the computer record.
He saw the person. It was the warmth in his eyes and 
the way that he sat relaxed in his chair. I don’t re-
member much from the consultation. I just remem-
ber the feeling (patient 18, woman aged 34 years).
The participants also wanted to see physicians and 
nurses who took a holistic approach to treatment and 
care, who took part in their lifeworld, not just the phys-
ical and mechanical components related to their disease; 
in other words, they wanted a compassionate physician or 
nurse. Indeed, the characteristics of the best physicians or 
nurses were emphasised as knowledge, warmth and trust, 
because such qualities were important for how the partic-
ipants felt, for their hopes and for how they dealt with 
their disease.
When I come to the cancer centre, I feel it’s about 
me. I know there are hundreds of people coming and 
going. But every time I come, I feel that they are tak-
ing care of me (patient 6, man 72 years)
The participants preferred to be treated by knowledge-
able HCPs who were able to answer questions. Some felt 
insecure if they were treated by a junior physician who 
could not answer all their questions.
I would have felt more secure if I was treated by a 
specialist, one who didn’t have to ask colleagues to 
be sure. At least occasionally (patient 11, man aged 
60 years).
Furthermore, the participants preferred to receive 
their test results immediately rather than to wait until 
their next appointment at the outpatient clinic or the 
cancer centre.
There were minor changes after the last computer 
tomography. The oncologist telephoned and told me 
the results. I didn’t have to wait for the next appoint-
ment, I didn’t have to worry until then (patient 17, 
woman aged 71 years).
Most participants wanted their healthcare and treat-
ment to be organised in such a way that it was possible 
to see the same physician at each consultation, and they 
appreciated small units/departments. The participants 
appreciated the possibility of contacting the physicians 
and nurses if needed, to have ‘an open door’. Some of 
those who had to alternate between different physicians 
felt that they had to start from the beginning each time, 
which they found exhausting.
I am an introverted person. I am not able to speak 
openly with everyone. When I meet a new physician, 
I have to start from the beginning, and I don’t like it. 
And it’s OK to feel like this. We’re all different (pa-
tient 2, woman aged 73 years).
In addition to the discomfiting feeling of having to 
deal with new physicians, some participants reported that 
information was not forwarded between the different 
physicians, resulting in misunderstandings. They felt inse-
cure and that no one was in charge of their medical care, 
for example, when experiencing changes in treatment at 
the same time as they changed physicians/junior doctors. 
Further, some participants highlighted that a lack of coor-
dination in treatment and care imposed an extra burden, 
and emphasised that confidence was inspired by better 
organisation and by the professional knowledge and 
ability of nurses and physicians to answer questions.
dIsCussIOn
To our knowledge, this is the first study to explore the 
thoughts of patients with colorectal cancer undergoing 
palliative care about how information was communicated 
about their disease, prognosis and life expectancy, from 
the first time that they were informed that their disease 
was incurable to postsurgery palliative treatment.
Evident in our findings was the asymmetrical relation-
ship in which the physicians held the knowledge and 
expertise about the disease and the participants had to 
trust them. As Løgstrup19 emphasises, trust is something 
fundamental to our lives and implies that you expose 
yourself to others and become vulnerable. Vulnerability 
implies that others are in control and hold their fellow 
humans’ lives in their hands. The responsibility of HCPs 
in such asymmetrical relationships is especially important 
in palliative care. The participants wanted information 
about their incurable cancer to be provided in a sensible 
and sensitive way, in a setting that allowed enough time. 
However, according to many of our participants, the 
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sufficient help to deal with the information and their 
vulnerability. Being the first to inform patients that they 
have an incurable disease is difficult, and bearers of bad 
news may later be blamed despite their best intentions to 
provide information in a sensitive manner. Furthermore, 
in surgical departments, there is limited time allocated for 
surgeon–patient communication, and doctors in surgical 
specialties are significantly more likely to be rated poorly 
than non-surgical specialists or GPs when breaking bad 
news.18
Previous studies highlight that palliative treatment 
implies hope. Hope is an important coping strategy 
in such patients,28 29 and has been described as essen-
tial for human life. The realistic hope for most of our 
participants was that something could be done to relieve 
their symptoms and potentially to postpone death, and 
to enable them to lead ordinary everyday lives and have 
the possibility of spending time with family and friends. 
Therefore, the participants emphasised the importance 
of HCPs including hope in their communications of 
disease, prognosis and life expectancy throughout the 
disease trajectory. Studies have shown that there is a fine 
balance between telling the truth and nurturing hope, 
and that there is a spectrum of hope, from hope for a 
cure to hope for living as normally as possible.16 30 This 
aspect was also identified in our study.
There was diversity in how detailed the participants 
wanted information about their disease and likely future 
prospects to be. Previous work indicates that patients 
with incurable cancer want truthful information about 
their disease, treatment and likely future prospects.31 32 
However, because of individual preferences, individu-
ally customised approaches would seem desirable,33 34 
and could be considered an important part of a patient’s 
lifeworld that should be attended to in communication 
between patients and physicians or nurses. Although all 
the participants in the present study were aware of the 
incurable nature of their disease, we did not explore 
the accuracy of their prognostic awareness. However, in 
a systematic review and meta-regression analysis, Chen 
et al35 identified that only half the patients with cancer 
with advanced disease accurately understood their 
prognosis.
In our study, the participants emphasised the impor-
tance of organising all their palliative treatment and care 
with well-qualified physician or nurse. They seemed to 
prefer that physician or nurse communications included 
what Mishler20 has characterised as the ‘voice of medi-
cine’, which mainly focuses on the symptoms and medical 
and technical problems or aspects of the disease. But they 
also wanted physicians and nurses to initiate commu-
nication focusing on the participants’ inner thoughts 
related to their illness, Me20 ‘voice of the lifeworld’, which 
included asking more open-ended questions. Physicians 
and nurses who do this are characterised as compas-
sionate caregivers.36
Implications for healthcare
It might be considered overly demanding to be the bearer 
of the bad news that a patient has an incurable disease. 
Some of our participants experienced the first informa-
tion about their incurable disease as delayed, insufficient, 
given in an inappropriate way or at an inappropriate 
place. This indicates that there is a need for increased 
focus on communication by HCPs both during their 
university studies and in hospitals.8 Furthermore, it would 
be desirable for surgeons to have more time allocated to 
conveying information and communicating with patients.
Physicians and nurses have extensive responsibilities in 
how they communicate with patients who have an incur-
able disease, particularly because of the asymmetrical 
relationship between patients and HCPs. The HCPs have 
knowledge about how the disease will most likely progress 
and about common psychological responses. However, the 
patients’ inner thoughts and lifeworld are not necessarily 
known to the HCPs. The responsibility to invite or initiate 
communication about the patients’ inner thoughts is in 
the hands of the physicians and nurses. Furthermore, it 
is important to strive for a more symmetrical relationship 
between patients and HCPs,19 28 which will also increase 
the possibility of shared decision-making in treatment 
and care.
The participants preferred compassionate physicians 
and nurses. Being compassionate requires more than 
empathy; it requires knowledge, proactivity and intercon-
nectedness.36 Furthermore, to become a compassionate 
physician or nurse, training is required involving observa-
tion, guidance and feedback about one’s own practice.36 
HCPs also need to be aware of how much information 
each patient prefers and discuss this with the patient. 
Previous studies have shown that this awareness is associ-
ated with years of practice and confidence.8 10 Treatment 
and care of patients undergoing palliative chemotherapy 
should be organised in such a way that patients are able 
to see the same well-qualified physician and optionally 
also the same nurses at each consultation. Furthermore, 
palliative healthcare should include guidelines on how to 
treat the patients more smoothly, and allow enough time 
for communication with this vulnerable patient group.
Methodological considerations
The strengths of the study are that the 20 participants 
provided us with rich data about their experiences, feel-
ings and reflections on the information and communi-
cation by HCPs about their disease and life expectancy 
during their disease trajectory. Qualitative content anal-
ysis aims to stay close to the data and texts to elucidate 
the findings, although our preunderstanding of the issues 
as researchers might also have influenced the analysis of 
the data. Another strength of our study is that it included 
patients with one type of cancer who were in the pallia-
tive phase. Colorectal cancer is the second most common 
cancer diagnosed in women worldwide, and the third 
most common cancer diagnosed in men21 22; thus, the 
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large group of patients. However, it is also possible that 
studying just one patient group might limit the variation 
in findings that may have been identified by including 
more heterogeneous groups. We have limited systematic 
information about the participants’ sociodemographic 
variables, common behaviour and coping mechanisms 
that might have influenced their experiences and pref-
erences. However, based on the few characteristics, we 
identified during the interviews, the variations in sociode-
mographic factors such as gender, age and marital status 
seem to be similar to those of patients with colorectal 
cancer reported by Jemal et al.21 Although our findings are 
not generalisable to patients with other cancer diagnoses, 
they may be transferable to hospitals with a similar organ-
isation of surgery and postsurgery palliative treatments.
COnClusIOns
The findings of this study provide a deeper under-
standing about how patients with incurable colorectal 
cancer undergoing palliative treatment experience and 
reflect on HCP–patient communication about disease 
and life expectancy from before surgery through to post-
surgery chemotherapy. The process of receiving the first 
information that they had an incurable disease was gener-
ally experienced as inadequate, while postsurgery pallia-
tive chemotherapy, physicians and nurses offered hope. 
The participants preferred customised information about 
treatment and likely future prospects, and physicians and 
nurses who used a holistic approach focusing on their 
lifeworld with compassion. To become a sensitive, holistic 
and compassionate physician or nurse requires knowl-
edge and confidence, and to achieve this, training and 
guidance are needed.
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